The CHEMSAS Promise
  advanced molecular screening
     
  novel activity mapping
     
  customized solutions
     
CHEMSAS Performance
     
  anti-hiv
     
  anti-cancer
     
  anti-arrhythmic
     
  anti-hypertensive
     
  anti-microbial
     
  glossary

 

 

Tumor Cell Testing Results

Committee of 10 ANN Results for 1028 molecules from the NCI/DTP database

Anti-Cancer Log GI50 Results
NCI Cell Type Testing R2 MSE* % in Range**
Leukemia 0.9503 0.017 98.5
NSCLC 0.9482 0.091 98.6
SCLC 0.9525 0.099 98.9
Colon 0.9525 0.088 98.5
CNS 0.9508 0.092 99.0
Melanoma 0.9495 0.092 98.5
Ovarian 0.9504 0.082 98.5
Renal 0.9502 0.089 98.6
Prostate 0.9492 0.098 98.5
Breast 0.9435 0.098 98.6
Mean 0.9497 0.094 98.62
95% CI +0.002 +0.004 +0.113

* - Mean Squared Error N = 1028 molecules
** - Percent of predictions within ± 1 dilution of actual log GI50

 



 

 

Critical Outcome Technologies Inc., © 2000-2001. All rights reserved.